Rare diseases
Investigational molecules
Locations
Back to France2 598 clinical trials in Paris, France across 36 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Cannabidiol for Treatment of Recurrent Pericarditis in Affected Patients
FranceA Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
FranceA study to evaluate the safety and effectiveness of KD033 in patients with advanced or metastatic solid tumors
FranceEfficacy and Safety of Maintenance Cabozantinib Plus Best Supportive Care in Pediatric and AYA Patients with Unresectable Residual Osteosarcoma
FranceA Study Testing the Safety and How Well GTX-102 Works in Adults and Children with Angelman Syndrome
FranceStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
FranceA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
FranceA Study of Raludotatug Deruxtecan for People with Gastrointestinal Cancers to Evaluate Safety and Effectiveness
FranceStudy of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer
FranceA study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia
FranceA Study Comparing Telisotuzumab Adizutecan to Trifluridine, Tipiracil, and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer
FranceA study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on head and neck squamous cell carcinoma and endometrial cancer, evaluating innovative treatment combinations and survival outcomes.
Clinical investigations targeting Type 1 Diabetes and obesity, with novel therapeutic approaches using tirzepatide for improved glycemic control.
Innovative vaccine trials for COVID-19, influenza, and cytomegalovirus, exploring both intranasal and injectable delivery methods.
Advanced research in multiple sclerosis and Alzheimer's disease, utilizing cutting-edge imaging techniques to study neuroinflammation and synaptic density.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
